Oxaprozin
Who holds supplier records for Oxaprozin? 4 organisations hold a current record for Oxaprozin: an active US FDA Type II Drug Master File. A further 9 organisations have only historical (inactive) DMF filings. Recorded organisation countries for current records: Italy (2), India (1) and Netherlands (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Oxaprozin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/oxaprozin
Reading the evidence
- 4 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (4)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Oxaprozin. Country is the organisation's recorded country, not necessarily the manufacturing site.
- COSMA SPAItaly Company GMP cert on recordActive DMF 12999 · latest filing May 1998
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 14428 · latest filing Sept 1999
- KATWIJK CHEMIE BVNetherlands Company GMP cert on recordActive DMF 11308 · latest filing Jan 1995
- OLON SPAItaly Company GMP cert on recordActive DMF 12911 · latest filing Mar 1998
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Historical records (9)
Organisations whose Type II DMFs for Oxaprozin are no longer active. These show a past filing, not current supply.
Show all 9 historical records
- SOCIETA ITALIANA MEDICINALI SCANDICCIInactive DMF 15484 · filed Jun 2001
- Italy · Inactive DMF 14059 · filed Apr 1999
- ZAMBON GROUP SPAInactive DMF 13227 · filed Sept 1998
- CHINA CHEMICAL SYNTHESIS INDUSTRIAL CO LTDInactive DMF 13119 · filed Aug 1998
- Italy · Inactive DMF 12340 · filed Jan 1997
- Switzerland · Inactive DMF 11867 · filed Feb 1996
- Spain · Inactive DMF 11862 · filed Feb 1996
- Japan · Inactive DMF 11748 · filed Nov 1995
- DSM PHARMA CHEMICALS SOUTH HAVEN INCInactive DMF 11156 · filed Oct 1994
Other forms of this substance
A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:
Overview
Oxaprozin is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1071).
Chemical identity
- IUPAC name
- 3-(4,5-diphenyl-1,3-oxazol-2-yl)propanoic acid
- Canonical SMILES
- C1=CC=C(C=C1)C2=C(OC(=N2)CCC(=O)O)C3=CC=CC=C3
- InChIKey
- OFPXSFXSNFPTHF-UHFFFAOYSA-N
- Synonyms
- Coxanto, Daypro, NSC-310839, Oxaprozin, Oxaprozina, Oxaprozine, WY-21,743, WY-21743, Alvo, Oxaprozinum, Deflam, 4,5-Diphenyl-2-oxazolepropionic acid
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Nonsteroidal Anti-inflammatory Drug
- Mechanism of action
- Cyclooxygenase Inhibitors
- Chemical structure
- Non-Steroidal
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Oxaprozin?
4 organisations hold an active US FDA Type II Drug Master File or a CEP for Oxaprozin: COSMA SPA (Italy), Dr. Reddy's Laboratories Ltd. (India), KATWIJK CHEMIE BV (Netherlands) and OLON SPA (Italy). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Oxaprozin Drug Master Files are active?
COSMA SPA (DMF 12999), Dr. Reddy's Laboratories Ltd. (DMF 14428), KATWIJK CHEMIE BV (DMF 11308) and OLON SPA (DMF 12911). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Oxaprozin records mean?
9 organisations have only inactive Type II DMFs for Oxaprozin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
How do I qualify a Oxaprozin supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Oxaprozin?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.